Fate Therapeutics Inc. (FATE) Climbed 9.68% or 1.43 To Price $16.21 On Monday


Fate Therapeutics Inc. (FATE) climbed 9.68% or 1.43 to $16.21. It is about 506857 shares traded, which is 50.47% compare to the average total volume 1.00 million. The market cap of FATE is $1.05 billion. The year to date change is 18.91%. The 52 week price range is from $6.24 to $17.98. Price of FATE have changed 22.45% during last week. It have changed -6.10% over last month, -1.20% over last 3 months, 18.81% over last 6 months and 124.28% over one year.

Some investors will use 50-day and 200-day Moving Averages as support and resistance levels. Those moving average will be very helpful most of time. The 50-day Moving Averages for FATE is 13.79. It is -14.93% below current price. The 200-day Moving Averages for FATE is 12.22. It is -24.61% below current price. The 52-week High is 17.98. It is 10.92% from the current price. The 52-week Low is 6.24. It is -61.51% from current price.

There are some statistics of FATE. It is has market cap $1.05 billion. The share outstanding is 64.52 million. The average volume is 1.00 million. The percent of top 15 Institution holding is 130.30%. Return on equity is how much of net income returned as a percentage of the total amount of shareholder equity found on the balance sheet. Return on equity (ROE) of FATE is -57.54%. Return on assets (ROA) is an indicator that shows how profitable a company is using its total assets to generate earnings. Return on Assets (ROA) of FATE is -43.21%.


Tags:

Share this post